Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Texas Back Institute is a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims...

Aemetis Reports First Quarter 2025 Financial Results

Aemetis Reports First Quarter 2025 Financial Results

California Ethanol passes $2 billion cumulative revenue milestone Aemetis Biogas increased sales by 10,100 MMBtu compared with same quarter last year Sales of investment tax credits resulted in cash proceeds of $19.0 million during Q1 2025 India Biodiesel received...

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

IRVINE, Calif., May 7, 2025 - PRISM MediaWire - Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte will host a live...